Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer – News-Medical.net
|
Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer
News-Medical.net The phase II KEYNOTE-059 is one of the largest studies to investigate immunotherapy in recurrent or metastatic gastric cancer. The study included three cohorts: 1) 259 patients with metastatic gastric cancer who received the programmed death 1 (PD-1) … |
